A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas ... highlighting its potential as an efficient and precise tool for gene editing applications. Establishment and robust expansion of human ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where Editas Medicine ... with CRISPR-Cas9 leading the charge.

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where Prime Medicine ... with CRISPR-Cas9 leading the charge.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

This ability to precisely target and cut DNA is the foundation for gene editing applications ... future, CRISPR diagnostics have the potential to transform the field of personalized medicine.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

CTX001 is an ‘ex vivo’ application of gene-editing, in which the technology is used to modify a patient’s own cells outside the body. It uses CRISPR/Cas9 to make a patient’s haematopoietic ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.